The Current Ratio as of December 2025 (TTM) for Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) is 118.02

According to Caliway Biopharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 118.02. This represents a change of -18.18% compared to the average of 144.24 of the last 4 quarters.

Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) Historical Current Ratio (quarterly & annually)

How has 6919.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Caliway Biopharmaceuticals Co., Ltd. over the last ten years is 46.00. The current 118.02 Current Ratio has changed 25.56% with respect to the historical average. Over the past ten years (40 quarters), 6919.TWO's Current Ratio was at its highest in in the December 2024 quarter at 184.02. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Caliway Biopharmaceuticals Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) Average Current Ratio

How has 6919.TWO Current Ratio performed in the past?

The current Current Ratio of Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) Current Ratio vs. Peers

How is 6919.TWO’s Current Ratio compared to its peers?

Caliway Biopharmaceuticals Co., Ltd.’s Current Ratio is greater than Pell Bio-Med Technology Co., Ltd. (2.51), greater than Sunmax Biotechnology Co., Ltd. (1.50), greater than Lin BioScience, Inc. (41.18), greater than EirGenix Inc. (6.86), greater than TaiMed Biologics Inc. (24.39), greater than Polaris Group (2.38), greater than Center Laboratories, Inc. (0.47), greater than Tanvex BioPharma, Inc. (2.17), greater than Oneness Biotech Co., Ltd. (36.62), greater than TTY Biopharm Company Limited (1.77),

Build a custom stock screener for Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Caliway Biopharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Caliway Biopharmaceuticals Co., Ltd. (6919.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Caliway Biopharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.